-
Jacobsen ED, Sharman JP, Oki Y, Advani RH, et al.
Brentuximab vedotin demonstrates objective responses in a phase 2 study of
relapsed/refractory DLBCL with variable CD30 expression. Blood 2015;125:1394-402.
-
Bayne CE, Williams SB, Cooperberg MR, Gleave ME, et al.
Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts
and Future Perspectives. Eur Urol 2015.
-
Morita M, Joyce D, Miller C, Fung JJ, et al.
Rejection triggers liver transplant tolerance: Involvements of
mesenchyme-mediated Immune Control Mechanisms. Hepatology 2015.
-
Danese S, Rudzinski J, Brandt W, Dupas JL, et al.
Tralokinumab for moderate-to-severe UC: a randomised, double-blind,
placebo-controlled, phase IIa study. Gut 2015;64:243-9.
-
Zhang B, Cohen JE, Bondy SJ, Selby P, et al.
Duration of nicotine replacement therapy use and smoking cessation: a
population-based longitudinal study. Am J Epidemiol 2015;181:513-20.
|